Literature DB >> 27919406

Pediatric surgical readmissions: Are they truly preventable?

Erin G Brown1, Jamie E Anderson2, Debra Burgess2, Richard J Bold2, Diana L Farmer2.   

Abstract

BACKGROUND/
PURPOSE: Reimbursement penalties for excess hospital readmissions have begun for the pediatric population. Therefore, research determining incidence and predictors is critical.
METHODS: A retrospective review of University HealthSystem Consortium database (N=258 hospitals; 2,723,621 patients) for pediatric patients (age 0-17years) hospitalized from 9/2011 to 3/2015 was performed. Outcome measures were 7-, 14-, and 30-day readmission rates. Hospital and patient characteristics were evaluated to identify predictors of readmission.
RESULTS: Readmission rates at 7, 14, and 30days were 2.1%, 3.1%, and 4.4%. For pediatric surgery patients (N=260,042), neither index hospitalization length of stay (LOS) nor presence of a complication predicted higher readmissions. Appendectomy was the most common procedure leading to readmission. Evaluating institutional data (N=5785), patients admitted for spine surgery, neurosurgery, transplant, or surgical oncology had higher readmission rates. Readmission diagnoses were most commonly infectious (37.2%) or for nausea/vomiting/dehydration (51.1%). Patients with chronic medical conditions comprised 55.8% of patients readmitted within 7days. 92.0% of patients requiring multiple rehospitalizations had comorbidities.
CONCLUSIONS: Readmission rates for pediatric patients are significantly lower than adults. Risk factors for adult readmissions do not predict pediatric readmissions. Readmission may be a misnomer for the pediatric surgical population, as most are related to chronic medical conditions and other nonmodifiable risk factors. LEVEL OF EVIDENCE: Level IV.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Preventable; Quality improvement; Readmission; Surgery

Mesh:

Year:  2016        PMID: 27919406     DOI: 10.1016/j.jpedsurg.2016.10.037

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

1.  Association of Procedures and Patient Factors With 30-Day Readmission Rates After Pediatric Surgery.

Authors:  Jamie E Anderson; Rebecca A Stark; Payam Saadai; Shinjiro Hirose
Journal:  JAMA Surg       Date:  2017-10-01       Impact factor: 14.766

2.  US pediatric trauma patient unplanned 30-day readmissions.

Authors:  Krista K Wheeler; Junxin Shi; Henry Xiang; Rajan K Thakkar; Jonathan I Groner
Journal:  J Pediatr Surg       Date:  2017-08-07       Impact factor: 2.545

3.  Nationwide outcomes of incidental appendectomy during cholecystectomy versus cholecystectomy alone in children: a propensity score-matched analysis.

Authors:  Carlos Theodore Huerta; Andrew Sundin; Antoine J Ribieras; Rebecca Saberi; Walter Ramsey; Gareth Gilna; Hallie J Quiroz; Chad M Thorson; Juan E Sola; Eduardo A Perez
Journal:  Pediatr Surg Int       Date:  2022-08-03       Impact factor: 2.003

4.  Pediatric Surgical Revisits by Specialty and Procedure Across US Children's Hospitals, 2016-2020.

Authors:  Christopher De Boer; Hassan Ghomrawi; Suhail Zeineddin; Samuel Linton; Yao Tian; Soyang Kwon; Fizan Abdullah
Journal:  JAMA       Date:  2022-08-23       Impact factor: 157.335

5.  Risk factors associated with paediatric unplanned hospital readmissions: a systematic review.

Authors:  Huaqiong Zhou; Pam A Roberts; Satvinder S Dhaliwal; Phillip R Della
Journal:  BMJ Open       Date:  2019-01-28       Impact factor: 2.692

6.  Understanding unplanned readmissions for children undergoing surgery in a single pediatric general surgical department.

Authors:  Chao Zheng; Hong Zhou; Hai Zhu; Bailin Chen; Lin Qiu; Chunbao Guo
Journal:  BMC Pediatr       Date:  2019-09-26       Impact factor: 2.125

7.  Association of Same-Day Discharge With Hospital Readmission After Appendectomy in Pediatric Patients.

Authors:  Sarah B Cairo; Mehul V Raval; Marybeth Browne; Holly Meyers; David H Rothstein
Journal:  JAMA Surg       Date:  2017-12-01       Impact factor: 14.766

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.